Impact of Oocytes With CLCG on ICSI Outcomes and Their Potential Relation to Pesticide Exposure
CLCG-ICSI
1 other identifier
observational
633
0 countries
N/A
Brief Summary
Oocyte quality is a key limiting factor in female fertility which is primarily reflected in morphological features. Centrally located cytoplasm granulation (CLCG) is one type of cytoplasmic dimorphism exhibited by oocytes that could be linked to pesticide exposure with a significant risk of decreased ICSI outcomes. This retrospective study included 633 women who were part of an intracytoplasmic spermatozoa injection (ICSI) program between 2009 and 2011. The participants lived in the Picardy region of France and had been exposed to pesticides. The participants were divided in two groups based on prevalence of oocytes with CLCG (LCLCG \[n= 83\]: low prevalence of oocytes with CLCG under 25%. HCLCG \[ n= 68\]: high prevalence of CLCG over 75%). The embryological and clinical outcomes were analysed for both groups and were calculated using the difference between the two values.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2011
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 6, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
June 6, 2017
CompletedFirst Submitted
Initial submission to the registry
August 23, 2018
CompletedFirst Posted
Study publicly available on registry
August 27, 2018
CompletedMay 17, 2023
August 1, 2018
6.4 years
August 23, 2018
May 16, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
ICS outcomes of couples presenting differetn CLCG prevalence
The aim of the present study was to investigate the ICSI outcomes of couples presenting different CLCG prevalence's of retrieved oocytes (low prevalence of CLCG; fewer than 25% \[LCLCG\] and high prevalence of CLCG; over 75% \[HCLCG\]) and its correlation to pesticide exposure zones in the region of Picardy, France.
2years
Eligibility Criteria
The population in the retrospective study consisted of 633 couples who attended a reproductive medical center and who were part of an ICSI program between 2009 and 2011. The study population is described in Table 1\. In the selected couples, women were normo-responders (oocyte cohort over 5), under 35 years old, living in the Picardy, France region, and exhibited CLCG after oocyte morphology evaluation which was confirmed by a second embryologist (Fig. 1
You may qualify if:
- couples who attendes a reproductive medical center
- couples that were part of a ICSI program between 2009 and 2011
- women were normo-responders
- female \> 18 years \<35 yeas old
You may not qualify if:
- female \< 18 years \> 35 yeas old
- couple with severe male infertility factors on oocyte activation and subsequent embryo development
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- PRINCIPAL INVESTIGATOR
Moncef Ben Khlifa, MD
CHU AMIENS
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2018
First Posted
August 27, 2018
Study Start
January 1, 2011
Primary Completion
June 6, 2017
Study Completion
June 6, 2017
Last Updated
May 17, 2023
Record last verified: 2018-08
Data Sharing
- IPD Sharing
- Will not share